Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00744159
Other study ID # IRB 2005-08-041
Secondary ID #CRS-106-14-1
Status Completed
Phase N/A
First received August 27, 2008
Last updated August 28, 2008
Start date January 2006
Est. completion date November 2007

Study information

Verified date August 2008
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study aimed to clarify existence of immunological benefit of laparoscopic colon cancer surgery compared to open colon surgery.


Description:

Patients with clinical stage Ⅲ left colon and upper rectal cancer were prospectively assigned to undergo LC (n=35) or OC (n=39). Factors related to cellular immunity of host (total lymphocyte count, CD4 lymphocyte, CD8 lymphocyte, CD4/CD8 ratio, HLA-DR expression on monocyte (mHLA-DR)) were examined preoperatively, on the 1st day of operation (POD1) and the 5th day of operation (POD5).


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date November 2007
Est. primary completion date November 2007
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Biopsy proven of colon cancer

- Preoperatively suspected as clinical stage III colon cancer

- Lesion located Descending colon, sigmoid colon and upper rectal cancer

Exclusion Criteria:

- Could not perform curative resection

- Intestinal obstruction, perforation, intra-abdominal abscess

- Severe medical illness

- Immunopathy

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Samsung Medical Center, Department of surgery Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Immune factors post OP 5th day No
Secondary Post-operative complications POD 7th days Yes
See also
  Status Clinical Trial Phase
Completed NCT02814617 - The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity Phase 2/Phase 3
Completed NCT02244372 - Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity N/A
Completed NCT00990002 - Investigation of A Children's Beverage Containing Different Probiotics N/A
Completed NCT00788021 - Protective Immunity Project 01 N/A
Completed NCT01736787 - Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity N/A
Recruiting NCT04579588 - Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Completed NCT04798677 - Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine N/A
Completed NCT05162820 - Impact of Solarplast® on Immunity in Active Smokers and Non-smokers N/A
Completed NCT01657656 - Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia N/A
Completed NCT05585021 - Clinical Study on the Effect of Probiotic Compound Powder on the Immunity Improvement of Preschool Children N/A
Recruiting NCT05117385 - The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune) N/A
Completed NCT05190237 - the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement. N/A
Completed NCT04647071 - Allium Extracts on the Incidence of Respiratory Infection Symptoms in Healthy Elderly Volunteers N/A
Completed NCT04031222 - Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes
Completed NCT04010331 - Efficacy and Safety of Nokyong Mixture Extract(CME-PI) on Promotion of Immunity N/A
Completed NCT03067714 - A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy Phase 3
Completed NCT04664309 - Understanding Immunity to the COVID-19 Vaccines
Withdrawn NCT06121362 - Effect of Protocatechuic Acid on Biochemical Markers of Immunity Status in Healthy Adults N/A
Recruiting NCT02166931 - BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition N/A
Recruiting NCT00645996 - The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants N/A